Citation Impact
Citing Papers
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
2018
Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199
2014
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
How chemokines organize the tumour microenvironment
2023
A view on drug resistance in cancer
2019 StandoutNature
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
2014
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
2020
Mitotic progression following DNA damage enables pattern recognition within micronuclei
2017 Nature
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
2021
Cancer drug resistance: an evolving paradigm
2013 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
2019
Hepatocellular carcinoma
2021 Standout
Mechanisms and consequences of Jak–STAT signaling in the immune system
2017
The immune contexture in cancer prognosis and treatment
2017 Standout
T Cell Dysfunction in Cancer
2018
The role of retrotransposable elements in ageing and age-associated diseases
2021 Nature
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
2019 Nature
Recent advances in the development of Mcl-1 inhibitors for cancer therapy
2019
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Engineering interferons and interleukins for cancer immunotherapy
2022
Delivery technologies for cancer immunotherapy
2019 Standout
The diverse functions of the PD1 inhibitory pathway
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Evading apoptosis in cancer
2013
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
2018
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Tumour-intrinsic resistance to immune checkpoint blockade
2019
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
2018
Immune checkpoint blockade therapy
2018
Interplay between dendritic cells and cancer cells
2019
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
2017
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
2019
Multidimensional Profiling in the Investigation of Small-Molecule-Induced Cell Death
2014
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Mitochondria as multifaceted regulators of cell death
2019 Standout
Type I Interferon in Chronic Virus Infection and Cancer
2017
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
2020
Small molecule Mcl-1 inhibitors for the treatment of cancer
2014
Interferons α and β in cancer: therapeutic opportunities from new insights
2019
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
2016
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Hyperprogressive disease: recognizing a novel pattern to improve patient management
2018
The role of MicroRNAs in human cancer
2016 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
2019
Fundamentals of cancer metabolism
2016 Standout
Targeting SOD1 reduces experimental non–small-cell lung cancer
2013
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
2019 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
2018
Iterative optimization yields Mcl-1–targeting stapled peptides with selective cytotoxicity to Mcl-1–dependent cancer cells
2018
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity
2021
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
2012
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Lisa Cucolo being referenced
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
2022
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
2016
Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
2012